New NRT gum
This article was originally published in The Tan Sheet
Gum containing 2 mg nicotine tartrate salt, rather than nicotine polacrilex, yields "faster and better craving relief," researchers announce at Ninth Annual Meeting of the Society for Research on Nicotine & Tobacco. Raymond Niaura, PhD, Brown Medical School, et al., led a randomized, multi-center, open-label study in which 319 participants lit a cigarette of their choice without inhaling and then chewed either GlaxoSmithKline's Nicorette 2 mg or the experimental gum. After 30 minutes, "92% of rapid-release gum chewers had achieved meaningful relief of craving, compared to only 77% of those on Nicorette," researchers note. Study was sponsored by Bayer Consumer Care. JSR, a Maryland firm that develops "novel treatments for tobacco dependence," noted it is working with Biovail on commercialization of this product. NDA submission for new OTC drug is one to two years away, as Phase III placebo-controlled trials still need to be completed...
You may also be interested in...
Rapid release nicotine gum may help smokers cope with cue-provoked or situation-induced cravings that may occur after quitting with traditional nicotine replacement therapy, according to a study published in the Sept. 9 online edition of Addiction
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.